258 related articles for article (PubMed ID: 11948462)
1. Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas.
Yan P; Benhattar J; Coindre JM; Guillou L
Int J Cancer; 2002 Apr; 98(6):851-6. PubMed ID: 11948462
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity.
Yan P; Coindre JM; Benhattar J; Bosman FT; Guillou L
Cancer Res; 1999 Jul; 59(13):3166-70. PubMed ID: 10397260
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in cell lines of pediatric soft tissue sarcomas.
Kleideiter E; Schwab M; Friedrich U; Koscielniak E; Schafer BW; Klotz U
Pediatr Res; 2003 Nov; 54(5):718-23. PubMed ID: 12904596
[TBL] [Abstract][Full Text] [Related]
5. Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas.
Matsuo T; Shay JW; Wright WE; Hiyama E; Shimose S; Kubo T; Sugita T; Yasunaga Y; Ochi M
J Bone Joint Surg Am; 2009 Apr; 91(4):928-37. PubMed ID: 19339578
[TBL] [Abstract][Full Text] [Related]
6. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
7. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
8. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
[TBL] [Abstract][Full Text] [Related]
9. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas.
Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M
Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028
[TBL] [Abstract][Full Text] [Related]
10. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of hTERT protein in human tissues.
Yan P; Benhattar J; Seelentag W; Stehle JC; Bosman FT
Histochem Cell Biol; 2004 May; 121(5):391-7. PubMed ID: 15138842
[TBL] [Abstract][Full Text] [Related]
12. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas.
Krams M; Claviez A; Heidorn K; Krupp G; Parwaresch R; Harms D; Rudolph P
Am J Pathol; 2001 Nov; 159(5):1925-32. PubMed ID: 11696453
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit (hTERT): a study of 143 benign and malignant soft tissue and bone tumours.
Patel RM; Folpe AL
Pathology; 2009; 41(6):527-32. PubMed ID: 19900100
[TBL] [Abstract][Full Text] [Related]
14. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
15. In situ detection of telomerase catalytic subunit mRNA in glioblastoma multiforme.
Falchetti ML; Pallini R; D'Ambrosio E; Pierconti F; Martini M; Cimino-Reale G; Verna R; Maira G; Larocca LM
Int J Cancer; 2000 Dec; 88(6):895-901. PubMed ID: 11093811
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo.
Cabuy E; de Ridder L
Virchows Arch; 2001 Aug; 439(2):176-84. PubMed ID: 11561758
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
18. Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas.
Yoo J; Robinson RA
Arch Pathol Lab Med; 2000 Mar; 124(3):393-7. PubMed ID: 10705392
[TBL] [Abstract][Full Text] [Related]
19. Correlations of telomere length, P53 mutation, and chromosomal translocation in soft tissue sarcomas.
Liu C; Li B; Li L; Zhang H; Chen Y; Cui X; Hu J; Jiang J; Qi Y; Li F
Int J Clin Exp Pathol; 2015; 8(5):5666-73. PubMed ID: 26191279
[TBL] [Abstract][Full Text] [Related]
20. Telomere maintenance in Wilms tumors: first evidence for the presence of alternative lengthening of telomeres mechanism.
Venturini L; Daidone MG; Motta R; Collini P; Spreafico F; Terenziani M; Piva L; Radice P; Perotti D; Zaffaroni N
Genes Chromosomes Cancer; 2011 Oct; 50(10):823-9. PubMed ID: 21769957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
